Valens Semiconductor Ltd. (VLN)
NYSE: VLN · Real-Time Price · USD
1.790
+0.140 (8.48%)
At close: Apr 24, 2026, 4:00 PM EDT
1.820
+0.030 (1.68%)
Pre-market: Apr 27, 2026, 6:16 AM EDT

Valens Semiconductor Earnings Call Transcripts

Fiscal Year 2025

  • Q4 and full year 2025 revenue exceeded guidance, driven by strong audio/video and automotive performance, with new chipsets and design wins fueling growth. 2026 revenue is projected to grow 8%, while a 10% workforce reduction aims to optimize costs.

  • Q3 2025 revenue and gross margin exceeded guidance, driven by strong CIB and POEV demand. Automotive margins dipped due to one-time costs but are expected to improve. Full-year revenue is projected to grow ~20%, with continued momentum in Pro AV, medical, and automotive segments.

  • The summit highlighted regulatory shifts driving institutional crypto adoption, with key beneficiaries in stablecoins, exchanges, and self-custody solutions. Precision Optics detailed growth in medical and defense optics, emphasizing single-use endoscopes. Valens Semiconductor outlined multi-vertical chip growth, targeting automotive ADAS and industrial vision, with ambitious 2029 financial goals.

  • The company is leveraging its advanced connectivity technology to expand across ProAV, automotive, industrial, and medical markets, with strong R&D investment and new products targeting significant growth opportunities. Despite near-term headwinds from tariffs and inventory corrections, long-term revenue is projected to grow 4–6x by 2029, driven by diversification and innovation.

  • Q2 2025 revenue and gross margin exceeded guidance, but full-year outlook was revised down due to global tariffs impacting customer forecasts. Strong demand in Pro AV and machine vision, multiple industry awards, and a completed $25M share repurchase highlight ongoing momentum.

  • Q1 2025 revenue exceeded guidance at $16.8M, with gross margin at 62.9% and improved segment performance. Strong momentum in Pro AV, machine vision, and automotive, with Mobileye and China partnerships driving future growth. Cash remains robust and 2025 guidance is unchanged.

  • The company is targeting aggressive growth across automotive, audio-video, industrial, and medical markets, leveraging its patented connectivity technology and strong market positions. Financial guidance anticipates a rebound in 2025 and long-term revenue growth to $220-$300 million by 2029, supported by new products, design wins, and strategic acquisitions.

Fiscal Year 2024

  • 2024 saw revenue and margin challenges from inventory digestion, but new design wins, product launches, and the Acroname acquisition set the stage for a 2025 turnaround. Guidance calls for 23%-31% revenue growth in 2025, with strong cash reserves and a focus on high-growth markets.

  • Investor Day 2024

    Plans call for quadrupling to sextupling revenue by 2029, driven by leadership in Pro AV, automotive, and industrial/machine vision markets, with a strong focus on standards, new product launches, and selective M&A. Gross margins and EBITDA are expected to improve as new markets ramp.

  • Q3 2024 revenue and gross margin exceeded guidance, driven by strong execution and new design wins in automotive and industrial markets. Cash position remains robust, with no customer concentration risk and positive outlook for continued growth.

  • Investor Update

    Three major European OEM design wins validate a robust ADAS solution with strong electromagnetic immunity, setting the stage for multi-year revenue growth as adoption expands from high-end to mainstream vehicles. The scalable chipset architecture and industry recognition position the company for accelerated future wins and significant market share.

  • Q2 2024 revenue exceeded guidance at $13.6M, driven by strong VS6320 chipset momentum and the Acroname acquisition. Despite year-over-year declines due to inventory digestion, guidance for Q3 anticipates revenue growth and continued ramp-up of new products.

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by